Today, President Donald J. Trump signed an Executive Order aimed at continuing efforts to lower prescription drug prices, a move tied closely to initiatives from his first term in office. The action emphasizes transparency and competition within the prescription drug market.
The President emphasized the significance of transparency and competition, declaring his commitment to ensuring the prescription drug market remains fair and transparent for American consumers. This initiative aligns with the administration's focus on patient-first policies.
The President reiterated his administration's dedication to placing American patients at the forefront by extending efforts initiated during his first term to reduce prescription drug prices.
